About us
Welcome to K3 Capital Group, a multi-disciplinary and complementary group of professional services businesses advising UK SMEs and private clients, with some operations overseas.
Our trading subsidiaries consist of KBS Corporate, KBS Corporate Finance, Knightsbridge, Knight Corporate Finance, Quantuma, randd, inTax, Knight R&D, K3 Tax Advisory, K3 Advantage, Origin IQ, HMA Tax, JE Consulting, Pinnacle, K3 Law, KR8 Advisory, Pareto Financial Planning and Luna Investment Management, offering Business Sales, Tax, Recovery, Technology Solutions and Financial Services.
K3 in numbers
years +
serving the SME market
UK offices
and operations overseas
staff
employed by K3
Why invest?
Unique, market leading
approach
We provide a range of specialist advisory services across Business Sales, Restructuring and Tax, based around a leading SME data set and marketing platform developed over the last 20 years
Resilient and scalable
business model
Over the last 5 years, we have trebled earnings and returned nearly £20m to shareholders. Today we have 3 divisions that blend high volume business sales revenues, contracted and recurring tax revenues and counter- cyclical restructuring services, giving us high visibility of future growth and profits
Highly profitable backed
by cash
We are experienced in delivering efficiencies to drive sector-leading profitability with c.30% EBITDA Group margins and c.50% across our Business Sales and Tax divisions. Our model is highly cash generative with FCF deployed on M&A and an attractive dividend payment
Investing for the
future
We are approaching 600 colleagues across the UK and overseas offices and have a culture of innovation and re-investing in our services, people and client relationships
Runway for further M&A
growth
We have a proven track record of identifying & integrating strategic acquisitions that deliver growth and synergies. Opportunity to leverage our SME data set and trusted client relationships into other related or complementary sectors that service SMEs
Ambitious management
team
We have less than a 5% market share today and our experienced leadership team, supported by our equity culture and growing “bench strength”, has the ambition to build towards £50m of EBITDA in the medium-term